Comparison of Direct Oral Anticoagulants Versus Low-Molecular-Weight-Heparins for the Treatment of Cancer Associated Thrombosis

被引：3
|
作者：
Phelps, Megan K.
Wiczer, Tracy E.
Erdeljac, H. Paige
Van Deusen, Kelsey R.
Porter, Kyle
Phillips, Gary
Wang, Tzu-Fei
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5013.5013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5013
引用
收藏
页数：6
相关论文
共 50 条
  • [1] COMPARATIVE EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS VERSUS LOW- MOLECULAR WEIGHT HEPARINS IN CANCER ASSOCIATED THROMBOSIS
    Yande, S.
    Johnson, M. L.
    Aparasu, R. R.
    Toale, K.
    Wanat, M.
    VALUE IN HEALTH, 2024, 27 (06) : S179 - S179
  • [2] Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
    Kaidireyahan Wumaier
    Wenqian Li
    Naifei Chen
    Jiuwei Cui
    Thrombosis Journal, 19
  • [3] Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
    Wumaier, Kaidireyahan
    Li, Wenqian
    Chen, Naifei
    Cui, Jiuwei
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [4] Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
    Munoz, Andres
    Gallardo, Enrique
    Agnelli, Giancarlo
    Crespo, Carlos
    Forghani, Monica
    Arumi, Daniel
    Fernandez de Cabo, Susana
    Soto, Javier
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 840 - 847
  • [5] Cost-effectiveness of apixaban versus other direct oral anticoagulants and low-molecular-weight-heparins for cancer associated venous thromboembolism in Spain.
    Munoz Martin, Andres J.
    Diaz, Enrique Gallardo
    Crespo, Carlos
    Domenech, Roma Masana
    Soto, Javier
    Arumi, Daniel
    Fernandez, Susana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Direct oral anticoagulants and cancer: no swansong yet for the low-molecular-weight heparins
    Noble, Simon I. R.
    Lancet Haematology, 2016, 3 (08): : E357 - E358
  • [7] Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism
    Park, Deborah Y.
    Poudel, Shyam K.
    Jia, Xuefei
    Wilks, Mailey Lynn
    Pinkava, Vicki
    O'Brien, Meghan
    Tripp, Barbara
    Song, Jung-Min
    McCrae, Keith R.
    Angelini, Dana E.
    Khorana, Alok A.
    BLOOD, 2018, 132
  • [8] Low-molecular weight heparin or direct oral anticoagulants for the treatment of cancer associated thrombosis. Are we at the crossroad?
    Meyer, Guy
    THROMBOSIS RESEARCH, 2019, 173 : 156 - 157
  • [9] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Guan, Tiffany
    Laguna, Arianna
    Soares, Alisha
    Legasto, Carlo S.
    Block, Shanna
    Saunders, Ila M.
    Alvarez, Kathryn
    Pon, Tiffany
    Patel, Nimish
    Mahajan, Anjlee
    Lee, Angela
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 439 - 446
  • [10] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Tiffany Guan
    Arianna Laguna
    Alisha Soares
    Carlo S. Legasto
    Shanna Block
    Ila M. Saunders
    Kathryn Alvarez
    Tiffany Pon
    Nimish Patel
    Anjlee Mahajan
    Angela Lee
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 439 - 446
12345